Elevating Pharmacovigilance
Through Intelligence, Insight, and Impact
At Aude Sapere, we transform pharmacovigilance from a compliance function into a strategic advantage — through expert-led consulting, intelligent regulatory insights, and next-generation capability building.
Led by a QPPV with 20+ years leading PV functions for biotech, CRO, and global pharma — including front-ending an MHRA inspection in 2025.
Supporting biotech, CRO, and pharmaceutical organisations across the UK, EU, US, and APAC
What We Do
We partner with pharmaceutical and biotech organisations to strengthen pharmacovigilance systems, regulatory intelligence, and operational excellence across the product lifecycle.
Our integrated model combines:
Our Core Pillars
PV & Quality Excellence
- End-to-end pharmacovigilance system design and optimisation
- QPPV office and inspection readiness support
- Quality oversight, audits, and governance frameworks
Built on direct QPPV and Deputy QPPV experience, not theory.
Regulatory Intelligence
(ASPIRE Reg Intel)- Continuous monitoring of global regulatory changes
- Impact assessments and actionable insights
- Authority-specific intelligence (MHRA, EMA, FDA, etc.)
Powered by AI and two decades of hands-on regulatory practice.
Capability Building
(ASPIRE Academy)- Role-based PV training programmes
- Inspection readiness simulations
- AI-enabled, modern learning experiences
Designed by practitioners who’ve sat across the table from MHRA, EMA, and FDA.
Why Aude Sapere
Strategic, not transactional
We embed long-term value, working as an extension of your team rather than a one-off vendor
Inspection-ready mindset
Built on real-world regulatory expectations, proven by direct experience front-ending MHRA, EMA, and FDA inspections
Modern PV thinking
Integrating AI, automation, and risk-based approaches through our own ASPIRE platforms
Tailored delivery
No “one-size-fits-all” solutions; every engagement is scoped to your stage, team, and regulatory footprint
